271 related articles for article (PubMed ID: 32921794)
1. A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis.
Davies C; Wilson R; Appiah-Kusi E; Blest-Hopley G; Brammer M; Perez J; Murray RM; Allen P; Bossong MG; McGuire P; Bhattacharyya S
Transl Psychiatry; 2020 Sep; 10(1):311. PubMed ID: 32921794
[TBL] [Abstract][Full Text] [Related]
2. Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis: A Randomized Clinical Trial.
Bhattacharyya S; Wilson R; Appiah-Kusi E; O'Neill A; Brammer M; Perez J; Murray R; Allen P; Bossong MG; McGuire P
JAMA Psychiatry; 2018 Nov; 75(11):1107-1117. PubMed ID: 30167644
[TBL] [Abstract][Full Text] [Related]
3. Increased hippocampal blood flow in people at clinical high risk for psychosis and effects of cannabidiol.
Davies C; Bossong MG; Martins D; Wilson R; Appiah-Kusi E; Blest-Hopley G; Zelaya F; Allen P; Brammer M; Perez J; McGuire P; Bhattacharyya S
Psychol Med; 2024 Apr; 54(5):993-1003. PubMed ID: 37845827
[TBL] [Abstract][Full Text] [Related]
4. Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis.
O'Neill A; Wilson R; Blest-Hopley G; Annibale L; Colizzi M; Brammer M; Giampietro V; Bhattacharyya S
Psychol Med; 2021 Mar; 51(4):596-606. PubMed ID: 31994476
[TBL] [Abstract][Full Text] [Related]
5. Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary report.
Davies C; Appiah-Kusi E; Wilson R; Blest-Hopley G; Bossong MG; Valmaggia L; Brammer M; Perez J; Allen P; Murray RM; McGuire P; Bhattacharyya S
Eur Arch Psychiatry Clin Neurosci; 2022 Apr; 272(3):461-475. PubMed ID: 34480630
[TBL] [Abstract][Full Text] [Related]
6. Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis.
Appiah-Kusi E; Petros N; Wilson R; Colizzi M; Bossong MG; Valmaggia L; Mondelli V; McGuire P; Bhattacharyya S
Psychopharmacology (Berl); 2020 Apr; 237(4):1121-1130. PubMed ID: 31915861
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol attenuates insular activity during motivational salience processing in patients with early psychosis.
Gunasekera B; Wilson R; O'Neill A; Blest-Hopley G; O'Daly O; Bhattacharyya S
Psychol Med; 2023 Jul; 53(10):4732-4741. PubMed ID: 35775365
[TBL] [Abstract][Full Text] [Related]
8. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.
Fusar-Poli P; Crippa JA; Bhattacharyya S; Borgwardt SJ; Allen P; Martin-Santos R; Seal M; Surguladze SA; O'Carrol C; Atakan Z; Zuardi AW; McGuire PK
Arch Gen Psychiatry; 2009 Jan; 66(1):95-105. PubMed ID: 19124693
[TBL] [Abstract][Full Text] [Related]
9. Neural Circuitry of Novelty Salience Processing in Psychosis Risk: Association With Clinical Outcome.
Modinos G; Allen P; Zugman A; Dima D; Azis M; Samson C; Bonoldi I; Quinn B; Gifford GWG; Smart SE; Antoniades M; Bossong MG; Broome MR; Perez J; Howes OD; Stone JM; Grace AA; McGuire P
Schizophr Bull; 2020 Apr; 46(3):670-679. PubMed ID: 32227226
[TBL] [Abstract][Full Text] [Related]
10. Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis.
Wilson R; Bossong MG; Appiah-Kusi E; Petros N; Brammer M; Perez J; Allen P; McGuire P; Bhattacharyya S
Transl Psychiatry; 2019 Aug; 9(1):203. PubMed ID: 31439831
[TBL] [Abstract][Full Text] [Related]
11. Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for Psychosis.
Modinos G; Kempton MJ; Tognin S; Calem M; Porffy L; Antoniades M; Mason A; Azis M; Allen P; Nelson B; McGorry P; Pantelis C; Riecher-Rössler A; Borgwardt S; Bressan R; Barrantes-Vidal N; Krebs MO; Nordentoft M; Glenthøj B; Ruhrmann S; Sachs G; Rutten B; van Os J; de Haan L; Velthorst E; van der Gaag M; Valmaggia LR; McGuire P;
JAMA Psychiatry; 2020 Feb; 77(2):190-200. PubMed ID: 31722018
[TBL] [Abstract][Full Text] [Related]
12. The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study.
Bloomfield MAP; Yamamori Y; Hindocha C; Jones APM; Yim JLL; Walker HR; Statton B; Wall MB; Lees RH; Howes OD; Curran VH; Roiser JP; Freeman TP
Psychopharmacology (Berl); 2022 May; 239(5):1539-1549. PubMed ID: 35445839
[TBL] [Abstract][Full Text] [Related]
13. Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study.
Winton-Brown TT; Allen P; Bhattacharyya S; Borgwardt SJ; Fusar-Poli P; Crippa JA; Seal ML; Martin-Santos R; Ffytche D; Zuardi AW; Atakan Z; McGuire PK
Neuropsychopharmacology; 2011 Jun; 36(7):1340-8. PubMed ID: 21412224
[TBL] [Abstract][Full Text] [Related]
14. Connectome dysfunction in patients at clinical high risk for psychosis and modulation by oxytocin.
Davies C; Martins D; Dipasquale O; McCutcheon RA; De Micheli A; Ramella-Cravaro V; Provenzani U; Rutigliano G; Cappucciati M; Oliver D; Williams S; Zelaya F; Allen P; Murguia S; Taylor D; Shergill S; Morrison P; McGuire P; Paloyelis Y; Fusar-Poli P
Mol Psychiatry; 2024 May; 29(5):1241-1252. PubMed ID: 38243074
[TBL] [Abstract][Full Text] [Related]
15. Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis.
Bhattacharyya S; Fusar-Poli P; Borgwardt S; Martin-Santos R; Nosarti C; O'Carroll C; Allen P; Seal ML; Fletcher PC; Crippa JA; Giampietro V; Mechelli A; Atakan Z; McGuire P
Arch Gen Psychiatry; 2009 Apr; 66(4):442-51. PubMed ID: 19349314
[TBL] [Abstract][Full Text] [Related]
16. Striatal cerebral blood flow, executive functioning, and fronto-striatal functional connectivity in clinical high risk for psychosis.
Hubl D; Schultze-Lutter F; Hauf M; Dierks T; Federspiel A; Kaess M; Michel C; Schimmelmann BG; Kindler J
Schizophr Res; 2018 Nov; 201():231-236. PubMed ID: 29983268
[TBL] [Abstract][Full Text] [Related]
17. Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.
Bhattacharyya S; Morrison PD; Fusar-Poli P; Martin-Santos R; Borgwardt S; Winton-Brown T; Nosarti C; O' Carroll CM; Seal M; Allen P; Mehta MA; Stone JM; Tunstall N; Giampietro V; Kapur S; Murray RM; Zuardi AW; Crippa JA; Atakan Z; McGuire PK
Neuropsychopharmacology; 2010 Feb; 35(3):764-74. PubMed ID: 19924114
[TBL] [Abstract][Full Text] [Related]
18. Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing.
Bhattacharyya S; Crippa JA; Allen P; Martin-Santos R; Borgwardt S; Fusar-Poli P; Rubia K; Kambeitz J; O'Carroll C; Seal ML; Giampietro V; Brammer M; Zuardi AW; Atakan Z; McGuire PK
Arch Gen Psychiatry; 2012 Jan; 69(1):27-36. PubMed ID: 22213786
[TBL] [Abstract][Full Text] [Related]
19. Probing the endocannabinoid system in healthy volunteers: Cannabidiol alters fronto-striatal resting-state connectivity.
Grimm O; Löffler M; Kamping S; Hartmann A; Rohleder C; Leweke M; Flor H
Eur Neuropsychopharmacol; 2018 Jul; 28(7):841-849. PubMed ID: 29887287
[TBL] [Abstract][Full Text] [Related]
20. Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes.
Modinos G; Richter A; Egerton A; Bonoldi I; Azis M; Antoniades M; Bossong M; Crossley N; Perez J; Stone JM; Veronese M; Zelaya F; Grace AA; Howes OD; Allen P; McGuire P
Neuropsychopharmacology; 2021 Jul; 46(8):1468-1474. PubMed ID: 33941857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
